by newsworm | Apr 2, 2025 | Mankind, Pharma
Mankind Pharma, India’s fourth-largest pharmaceutical company, has launched a new campaign for its HealthOK 100% vegetarian multivitamin tablets, featuring actress Archana Puran Singh. The campaign is aimed at raising awareness about the brand’s 100%... by newsworm | Apr 2, 2025 | Biocon, Pharma
Here is a 400-word summary of the content: Biocon’s CEO, Peter Bains, has resigned from his position. The news comes as a surprise, as Bains has led the company for nearly a decade, playing a significant role in its growth and success. His departure has left the... by newsworm | Apr 2, 2025 | Glenmark, Pharma
Glenmark has announced the launch of its generic version of Mylan’s Vancomycin Hydrochloride for Injection, which is now available in three concentrations: 750 mg/vial, 1.25 g/vial, and 1.5 g/vial (Single-dose vial). According to IQVIA, the market value of... by newsworm | Apr 2, 2025 | Cipla, Lupin, Pharma
The latest survey on the Doxorubicin market has been conducted to provide a comprehensive analysis of the market’s performance, competitive environment, and market size. The report covers the period from 2019 to 2024 and provides a forecast till 2031. The market... by newsworm | Apr 2, 2025 | Pharma
The former Dr. Reddy’s Laboratories pharmaceutical manufacturing site in Shreveport, Louisiana, is now up for sale. The 56-acre property, which was once home to 107 employees, was sold to Jaguar Labs Holdings, LLC, an affiliate of Ten Oaks Group. Realtor Chris... by newsworm | Apr 1, 2025 | Apollo Hospital, Pharma
Here is a summary of the content in 400 words: Apollo Hospitals, a leading healthcare provider, has launched a Genomics Institute in Karnataka to advance the field of precision medicine. The institute is dedicated to understanding the genetic basis of diseases and... by newsworm | Apr 1, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Torrent Pharma, Zydus
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as... by newsworm | Apr 1, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Torrent Pharma, Zydus
Here is a summary of the content in 400 words: Citi, a brokerage firm, has analyzed the potential impact of US tariffs on Indian pharmaceutical companies. While the likelihood of such a scenario is low, Citi’s analysis suggests that certain companies could face... by newsworm | Apr 1, 2025 | Natco, Pharma
Here’s a summary of the content in 400 words: The story revolves around a rare genetic disease called Spinal Muscular Atrophy (SMA) that affects 1 in 7,700 people in India. The only treatment available is a drug called Risdiplam, sold as Evrysdi by Swiss pharma... by newsworm | Apr 1, 2025 | Glenmark, Pharma
A UK High Court Judge, Michael Tappin, has rejected a request by AstraZeneca (AZ) and AstraZeneca UK Ltd. for an interim injunction to block Glenmark Pharmaceuticals Europe from launching a generic version of AZ’s diabetes drug, Forxiga. The generic version,...